Many studies have indicated that overt use of information technology leads to technostress, which is defined as “stress or psychosomatic illness caused by working with computer technology on a daily basis."
Because medications to treat these conditions are often controlled substances, including pharmacists on the multidisciplinary team (MDT) is invaluable.
Do supplements work against colds, flu? - Sidney Daily News sidneydailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sidneydailynews.com Daily Mail and Mail on Sunday newspapers.
Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing the right excipient is paramount for the adequate clinical performance of a robust dosage form. This choice must be .
Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology
ACCESSWIRE
LONDON, UK / ACCESSWIRE / May 24, 2021 /
Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced the Company had been granted patent protection in multiple territories for the use of its Molecular Envelope Technology (MET) for ocular applications.
These patents have been granted by the European Patent Office (EP3215119 ), the United States Patent and Trademark Office (US10987304) and the Japan Patent Office (JP6832276). Nanomerics Ltd. also today announced the publication of two key papers on the topical ocular use of its penetration-enhancing Molecular Envelope Technology (Pharmaceutics 2021, 13(5), 744